Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer’s disease
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0317303 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Matilde Nerattini und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Weill Cornell Medicine, New York, NY, United States of America. Hauptthemen laut MEDLINE: Testosterone, Alzheimer Disease, Gray Matter, Cerebrovascular Circulation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCATS NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Testosterone, an essential sex steroid hormone, influences brain health by impacting neurophysiology and neuropathology throughout the lifespan in both genders. However, human research in this area is limited, particularly in women. This study examines the associations between testosterone levels, gray matter volume (GMV) and cerebral blood flow (CBF) in midlife individuals at risk for Alzheimer’s disease (AD), according to sex and menopausal status. A cohort of 294 cognitively normal midlife participants, 83% female, ages 35–65 years, with an AD family history and/or Apolipoprotein E epsilon 4 (APOE-4) genotype, underwent volumetric Magnetic Resonance Imaging (MRI) to measure GMV and MR-Arterial Spin Labeling (ASL) for measurement of CBF. We used voxel-based analysis and volumes of interest to test for associations between testosterone (both total and free testosterone) and brain imaging outcomes, stratified by sex and menopausal status. Higher total and free testosterone levels were associated with larger GMV in men, with peak effects in frontal and temporal regions. Conversely, in women, higher testosterone levels correlated with higher CBF, with peak effects in frontal and limbic regions, subcortical areas and hypothalamus. Among women, associations between testosterone and GMV were observed at the premenopausal and perimenopausal stages, but not postmenopause, whereas associations of testosterone with CBF were significant starting at the perimenopausal stage and were more pronounced among hormone therapy non-users. Results were independent of age, APOE-4 status, midlife health indicators, and sex hormone-binding globulin levels. These findings indicate sex-specific neurophysiological effects of testosterone in AD-vulnerable regions in midlife individuals at risk for AD, with variations observed across sex and menopausal status. This underscores the need for further research focusing on the neuroprotective potential of testosterone in both sexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Weill Cornell Medicine, New York, NY, United States of America.
- Department of Experimental and Clinical Biomedical Sciences, Nuclear Medicine Unit, University of Florence, Florence, Italy.
- Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States of America.
- Department of Radiology, Weill Cornell Medicine, New York, NY, United States of America.
- ADM Diagnostics, Chicago, IL, United States of America.
- Department of Neurology and Pharmacology, University of Arizona, Tucson, AZ, United States of America.
ORCID-Profile: Matilde Nerattini, Jonathan P Dyke
Förderung
- NIA NIH HHS
- NCATS NIH HHS
- National Institute on Aging
- National Center for Advancing Translational Sciences
- Cure Alzheimer's Fund
- Women’s Alzheimer’s Movement
- Luminescence Foundation
- philanthropic support to the WCM Alzheimer’s Prevention Program
Zitieren
APA
Nerattini, M., Williams, S., Andy, C., Carlton, C., Zarate, C., Boneu, C., Fauci, F., Ajila, T., Jett, S., Battista, M., Pahlajani, S., Berti, V., Andrews, R., Matthews, D. C., Dyke, J. P., Brinton, R. D., & Mosconi, L. (2025). Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer’s disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0317303
Vancouver
Nerattini M, Williams S, Andy C, Carlton C, Zarate C, Boneu C, et al. Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer’s disease. PLOS ONE. 2025. doi:10.1371/journal.pone.0317303
BibTeX
@article{Nerattini2025,
author = {Nerattini, Matilde and Williams, Schantel and Andy, Caroline and Carlton, Caroline and Zarate, Camila and Boneu, Camila and Fauci, Francesca and Ajila, Trisha and Jett, Steven and Battista, Michael and Pahlajani, Silky and Berti, Valentina and Andrews, Randolph and Matthews, Dawn C and Dyke, Jonathan P and Brinton, Roberta Diaz and Mosconi, Lisa},
title = {Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer’s disease},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0317303}
}
EUVIMED